PAUL FINE to Immunogenicity, Vaccine
This is a "connection" page, showing publications PAUL FINE has written about Immunogenicity, Vaccine.
Connection Strength
0.198
-
The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi. Lancet Infect Dis. 2021 11; 21(11):1590-1597.
Score: 0.163
-
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. Clin Infect Dis. 2019 05 30; 68(12):2079-2086.
Score: 0.035